Viewing Study NCT02196961


Ignite Creation Date: 2025-12-24 @ 12:57 PM
Ignite Modification Date: 2026-01-22 @ 6:25 PM
Study NCT ID: NCT02196961
Status: COMPLETED
Last Update Posted: 2025-04-09
First Post: 2014-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation
Sponsor: Prof. Dr. med. Dirk Schadendorf
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Merkel Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Merkel cell carcinoma View
None Adjuvant View
None Nivolumab View